Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 15706475)

Published in Semin Thromb Hemost on February 01, 2005

Authors

Emmanuel J Favaloro1, Roslyn Bonar, John Sioufi, Michael Wheeler, Joyce Low, Margaret Aboud, Elizabeth Duncan, Julian Smith, Tom Exner, John Lloyd, Katherine Marsden, RCPA QAP in Haematology

Author Affiliations

1: Haematology Laboratories, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, New South Wales, Australia. emmanuel@icpmr.wsahs.nsw.gov.au

Articles by these authors

Cytokines and alcohol. Alcohol Clin Exp Res (2006) 2.04

The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas. Development (2005) 1.98

To be or not to be a flatworm: the acoel controversy. PLoS One (2009) 1.59

Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem (2013) 1.25

Genome-wide sequencing data reveals virulence factors implicated in banana Xanthomonas wilt. FEMS Microbiol Lett (2010) 1.25

Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab (2004) 1.21

Toward improved statistical reporting in the journal of consulting and clinical psychology. J Consult Clin Psychol (2005) 1.15

Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41. PLoS Pathog (2010) 1.14

Preliminary evaluation of reliability and criterion validity of Actiwatch-Score. J Rehabil Res Dev (2007) 1.13

Cytogenetic investigations of chronic lymphocytic leukemia. Cancer Genet Cytogenet (2010) 1.09

Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study. J Oral Maxillofac Surg (2003) 1.08

Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design. Am Heart J (2007) 1.06

Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatry (2005) 1.06

Laboratory testing for the new oral anticoagulants: a review of current practice. Pathology (2013) 1.02

Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg (2013) 1.00

Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay. Br J Haematol (2008) 1.00

Reversible dementia with psychosis: Hashimoto's encephalopathy. Psychiatry Clin Neurosci (2006) 0.99

Enhanced A3 adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates. J Nanobiotechnology (2008) 0.99

Development and evaluation of a multifaceted ergonomics program to prevent injuries associated with patient handling tasks. Int J Nurs Stud (2005) 0.96

Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation. Blood Coagul Fibrinolysis (2004) 0.94

Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue. J Thorac Cardiovasc Surg (2005) 0.93

Neuropsychiatric morbidity in focal epilepsy. Br J Psychiatry (2008) 0.92

An Australian risk prediction model for 30-day mortality after isolated coronary artery bypass: the AusSCORE. J Thorac Cardiovasc Surg (2009) 0.92

An HIV RNase H inhibitory 1,3,4,5-tetragalloylapiitol from the African plant Hylodendron gabunensis. J Nat Prod (2007) 0.91

Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors. Semin Thromb Hemost (2010) 0.89

An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP. J Psychiatr Res (2006) 0.88

Generation and characterization of mice with null mutation of the chloride intracellular channel 1 gene. Genesis (2010) 0.88

Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study. Thromb Haemost (2007) 0.86

Biomechanical evaluation of injury severity associated with patient falls from bed. Rehabil Nurs (2008) 0.86

Tagged fragment method for evolutionary structure-based de novo lead generation and optimization. J Med Chem (2007) 0.85

How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspective. Lab Hematol (2005) 0.84

An electromechanical based deformable model for soft tissue simulation. Artif Intell Med (2009) 0.83

Future directions in research with presymptomatic individuals carrying the gene for Huntington's disease. Brain Res Bull (2003) 0.83

Systematic screening of compressed ODT excipients: cellulosic versus non-cellulosic. Curr Drug Deliv (2014) 0.83

Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multilaboratory test process. Haemophilia (2004) 0.82

Multivalent dendrimeric and monomeric adenosine agonists attenuate cell death in HL-1 mouse cardiomyocytes expressing the A(3) receptor. Biochem Pharmacol (2010) 0.82

Stem cells propagate their DNA by random segregation in the flatworm Macrostomum lignano. PLoS One (2012) 0.82

Clinical reasoning in musculoskeletal practice: students' conceptualizations. Phys Ther (2009) 0.82

A single-centre prospective study of clinical and haemostatic risk factors for venous thromboembolism following lower limb arthroplasty. Br J Haematol (2005) 0.82

The effects of Asian population substructure on Y STR forensic analyses. Leg Med (Tokyo) (2008) 0.82

Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia. Semin Thromb Hemost (2010) 0.82

Using solar-powered refrigeration for vaccine storage where other sources of reliable electricity are inadequate or costly. Vaccine (2013) 0.82

External quality assurance for heparin monitoring. Semin Thromb Hemost (2012) 0.81

An international survey of current practice in the laboratory assessment of anticoagulant therapy with heparin. Pathology (2005) 0.81

AORN Ergonomic Tool 4: Solutions for Prolonged Standing in Perioperative Settings. AORN J (2011) 0.81

Robust neural network motion tracking control of piezoelectric actuation systems for micro/nanomanipulation. IEEE Trans Neural Netw (2009) 0.80

A cellular neural network methodology for deformable object simulation. IEEE Trans Inf Technol Biomed (2006) 0.80

AORN ergonomic tool 2: positioning and repositioning the supine patient on the OR bed. AORN J (2011) 0.80

Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification. Clin Lab Sci (2008) 0.80

Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II--Lupus anticoagulant. Semin Thromb Hemost (2012) 0.79

Correlation of selection scores with subsequent assessment scores during surgical training. ANZ J Surg (2013) 0.79

A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid. Blood Coagul Fibrinolysis (2003) 0.79

Problems and solutions in laboratory testing for hemophilia. Semin Thromb Hemost (2013) 0.79

Comparison of tyrosine kinase receptors HER2, EGFR, and VEGFR expression in micropapillary urothelial carcinoma with invasive urothelial carcinoma. Target Oncol (2014) 0.79

N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolase. Bioorg Med Chem Lett (2004) 0.79

Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation. Pathology (2007) 0.78

Fibrinogen Darlinghurst: hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications. Thromb Haemost (2006) 0.78

A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentrates. Thromb Haemost (2002) 0.78

Bilateral atraumatic sequential rupture of tibialis anterior tendons. Foot Ankle Spec (2010) 0.78

Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance program. Semin Thromb Hemost (2006) 0.77

Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies. Thromb Res (2010) 0.77

Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist. J Med Chem (2013) 0.77

Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation. Thromb Haemost (2006) 0.77

Reducing the use of diagnostic imaging in patients with suspected pulmonary embolism: validation of a risk assessment strategy. Emerg Med Australas (2005) 0.77

Interprofessional non-technical skills for surgeons in disaster response: a literature review. J Interprof Care (2013) 0.77

Estimation of hERG inhibition of drug candidates using multivariate property and pharmacophore SAR. Bioorg Med Chem (2007) 0.76

Time to think outside the box? Proposals for a new approach to future pharmacokinetic studies of von Willebrand factor concentrates in people with von Willebrand disease. Semin Thromb Hemost (2007) 0.76